Prospective Grant of Exclusive License: Devices for Clearing Mucus From Endotracheal Tubes, 52961 [2011-21685]

Download as PDF Federal Register / Vol. 76, No. 164 / Wednesday, August 24, 2011 / Notices Dated: August 18, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2011–21679 Filed 8–23–11; 8:45 am] Prospective Grant of Exclusive License: Devices for Clearing Mucus From Endotracheal Tubes National Institutes of Health BILLING CODE 4140–01–P National Institutes of Health, Public Health Service, HHS. ACTION: Notice. AGENCY: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health wreier-aviles on DSKGBLS3C1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel, Neuro Therapeutics Course. Date: August 31, 2011. Time: 2:45 p.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Phillip F. Wiethorn, Scientific Review Officer, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard, MSC 9529, Neuroscience Center, Room 3203, Bethesda, MD 20892–9529, 301–496–5388, wiethorp@ninds.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: August 18, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–21678 Filed 8–23–11; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 15:40 Aug 23, 2011 Jkt 223001 This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), Department of Health and Human Services (HHS), is contemplating the grant of a worldwide exclusive license, to practice the invention embodied in: HHS Ref. No. E– 061–2004/0 ‘‘Mucus Shaving Apparatus for Endotracheal Tubes’’; U.S. Patent 7,051,737 to EndOclear, LLC, a company incorporated under the laws of the State of Michigan having its headquarters in Petoskey, Michigan. The United States of America is the assignee of the rights of the above inventions. The contemplated exclusive license may be granted in a field of use limited to devices for clearing mucus from endotracheal tubes. DATES: Only written comments and/or applications for a license received by the NIH Office of Technology Transfer on or before September 23, 2011 will be considered. ADDRESSES: Requests for a copy of the patent application, inquiries, comments and other materials relating to the contemplated license should be directed to: Michael A. Shmilovich, Esq., Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, Rockville, MD 20852–3804; Telephone: (301) 435– 5019; Facsimile: (301) 402–0220; E-mail: shmilovm@mail.nih.gov. A signed confidentiality nondisclosure agreement will be required to receive copies of any patent applications that have not been published or issued by the United States Patent and Trademark Office or the World Intellectual Property Organization. SUPPLEMENTARY INFORMATION: The patent intended for licensure covers an endotracheal tube cleaning apparatus which is inserted into the inside of an endotracheal tube to shave away mucus deposits. Mucus deposits contribute to bacterial growth and put intubated patients at risk for ventilator associated pneumonia (VAP). The preferred embodiment as recited in the claims is a cleaning apparatus with a flexible central tube and an inflatable balloon at its distal end. Affixed to the inflatable SUMMARY: National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 52961 balloon are one or more shaving rings each having a squared leading edge to shave away mucus accumulations. In operation, the uninflated cleaning apparatus is inserted into the endotracheal tube and the balloon is then inflated by a suitable inflation device, such as a syringe, until the balloon’s shaving rings are pressed against the inside surface of the endotracheal tube. The cleaning apparatus is then pulled out of the endotracheal tube to shave off mucus deposits. The prospective exclusive license will be royalty bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published notice, NIH receives written evidence and argument that establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Properly filed competing applications for a license filed in response to this notice will be treated as objections to the contemplated license. Comments and objections submitted in response to this notice will not be made available for public inspection, and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552. Dated: August 16, 2011. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2011–21685 Filed 8–23–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Citizenship and Immigration Services Agency Information Collection Activities: Form N–300; Revision of an Existing Information Collection; Comment Request 60-Day Notice of Information Collection Under Review; Form N–300, Application to File Declaration of Intention; OMB Control No. 1615–0078. ACTION: The Department Homeland Security, U.S. Citizenship and Immigration Services (USCIS) will be submitting the following information collection request for review and clearance in accordance with the Paperwork Reduction Act of 1995. The information collection is published to obtain comments from the E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 76, Number 164 (Wednesday, August 24, 2011)]
[Notices]
[Page 52961]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21685]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: Devices for Clearing 
Mucus From Endotracheal Tubes

AGENCY: National Institutes of Health, Public Health Service, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i), that the National Institutes of Health (NIH), 
Department of Health and Human Services (HHS), is contemplating the 
grant of a worldwide exclusive license, to practice the invention 
embodied in: HHS Ref. No. E-061-2004/0 ``Mucus Shaving Apparatus for 
Endotracheal Tubes''; U.S. Patent 7,051,737 to EndOclear, LLC, a 
company incorporated under the laws of the State of Michigan having its 
headquarters in Petoskey, Michigan. The United States of America is the 
assignee of the rights of the above inventions. The contemplated 
exclusive license may be granted in a field of use limited to devices 
for clearing mucus from endotracheal tubes.

DATES: Only written comments and/or applications for a license received 
by the NIH Office of Technology Transfer on or before September 23, 
2011 will be considered.

ADDRESSES: Requests for a copy of the patent application, inquiries, 
comments and other materials relating to the contemplated license 
should be directed to: Michael A. Shmilovich, Esq., Office of 
Technology Transfer, National Institutes of Health, 6011 Executive 
Boulevard, Suite 325, Rockville, MD 20852-3804; Telephone: (301) 435-
5019; Facsimile: (301) 402-0220; E-mail: shmilovm@mail.nih.gov. A 
signed confidentiality nondisclosure agreement will be required to 
receive copies of any patent applications that have not been published 
or issued by the United States Patent and Trademark Office or the World 
Intellectual Property Organization.

SUPPLEMENTARY INFORMATION: The patent intended for licensure covers an 
endotracheal tube cleaning apparatus which is inserted into the inside 
of an endotracheal tube to shave away mucus deposits. Mucus deposits 
contribute to bacterial growth and put intubated patients at risk for 
ventilator associated pneumonia (VAP). The preferred embodiment as 
recited in the claims is a cleaning apparatus with a flexible central 
tube and an inflatable balloon at its distal end. Affixed to the 
inflatable balloon are one or more shaving rings each having a squared 
leading edge to shave away mucus accumulations. In operation, the 
uninflated cleaning apparatus is inserted into the endotracheal tube 
and the balloon is then inflated by a suitable inflation device, such 
as a syringe, until the balloon's shaving rings are pressed against the 
inside surface of the endotracheal tube. The cleaning apparatus is then 
pulled out of the endotracheal tube to shave off mucus deposits.
    The prospective exclusive license will be royalty bearing and will 
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. 
The prospective exclusive license may be granted unless, within thirty 
(30) days from the date of this published notice, NIH receives written 
evidence and argument that establishes that the grant of the license 
would not be consistent with the requirements of 35 U.S.C. 209 and 37 
CFR 404.7.
    Properly filed competing applications for a license filed in 
response to this notice will be treated as objections to the 
contemplated license. Comments and objections submitted in response to 
this notice will not be made available for public inspection, and, to 
the extent permitted by law, will not be released under the Freedom of 
Information Act, 5 U.S.C. 552.

    Dated: August 16, 2011.
Richard U. Rodriguez,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer, National Institutes of Health.
[FR Doc. 2011-21685 Filed 8-23-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.